Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patrícia Izquierdo Cafrune is active.

Publication


Featured researches published by Patrícia Izquierdo Cafrune.


BMC Microbiology | 2006

Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology

Karine Brudey; Jeffrey Driscoll; Leen Rigouts; Wolfgang M. Prodinger; Andrea Gori; Sahal A Al-Hajoj; Caroline Allix; Liselotte Aristimuño; Jyoti Arora; Viesturs Baumanis; Lothar Binder; Patrícia Izquierdo Cafrune; Angel Cataldi; Soonfatt Cheong; Roland Diel; Christopher Ellermeier; Jason T Evans; Maryse Fauville-Dufaux; Séverine Ferdinand; Darío García de Viedma; Carlo Garzelli; Lidia Gazzola; Harrison Magdinier Gomes; M Cristina Guttierez; Peter M. Hawkey; Paul D. van Helden; Gurujaj V Kadival; Barry N. Kreiswirth; Kristin Kremer; Milan Kubin

BackgroundThe Direct Repeat locus of the Mycobacterium tuberculosis complex (MTC) is a member of the CRISPR (Clustered regularly interspaced short palindromic repeats) sequences family. Spoligotyping is the widely used PCR-based reverse-hybridization blotting technique that assays the genetic diversity of this locus and is useful both for clinical laboratory, molecular epidemiology, evolutionary and population genetics. It is easy, robust, cheap, and produces highly diverse portable numerical results, as the result of the combination of (1) Unique Events Polymorphism (UEP) (2) Insertion-Sequence-mediated genetic recombination. Genetic convergence, although rare, was also previously demonstrated. Three previous international spoligotype databases had partly revealed the global and local geographical structures of MTC bacilli populations, however, there was a need for the release of a new, more representative and extended, international spoligotyping database.ResultsThe fourth international spoligotyping database, SpolDB4, describes 1939 shared-types (STs) representative of a total of 39,295 strains from 122 countries, which are tentatively classified into 62 clades/lineages using a mixed expert-based and bioinformatical approach. The SpolDB4 update adds 26 new potentially phylogeographically-specific MTC genotype families. It provides a clearer picture of the current MTC genomes diversity as well as on the relationships between the genetic attributes investigated (spoligotypes) and the infra-species classification and evolutionary history of the species. Indeed, an independent Naïve-Bayes mixture-model analysis has validated main of the previous supervised SpolDB3 classification results, confirming the usefulness of both supervised and unsupervised models as an approach to understand MTC population structure. Updated results on the epidemiological status of spoligotypes, as well as genetic prevalence maps on six main lineages are also shown. Our results suggests the existence of fine geographical genetic clines within MTC populations, that could mirror the passed and present Homo sapiens sapiens demographical and mycobacterial co-evolutionary history whose structure could be further reconstructed and modelled, thereby providing a large-scale conceptual framework of the global TB Epidemiologic Network.ConclusionOur results broaden the knowledge of the global phylogeography of the MTC complex. SpolDB4 should be a very useful tool to better define the identity of a given MTC clinical isolate, and to better analyze the links between its current spreading and previous evolutionary history. The building and mining of extended MTC polymorphic genetic databases is in progress.


European Journal of Clinical Pharmacology | 2008

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

Lia Gonçalves Possuelo; J. A. Castelan; T. C. de Brito; Andrezza Wolowski Ribeiro; Patrícia Izquierdo Cafrune; P. D. Picon; Adalberto R. Santos; Raquel Lima de Figueiredo Teixeira; Tatiana Schäffer Gregianini; Mara H. Hutz; Maria Lucia Rosa Rossetti; Arnaldo Zaha

PurposeTo determine the frequency of N-acetyltransferase 2 (NAT2) polymorphisms, the NAT2 acetylation profile and its relation to the incidence of gastrointestinal adverse drug reactions (ADRs), anti-tuberculosis (TB) drug-induced hepatotoxicity, and the clinical risk factors for hepatotoxicity in a population from Brazil.MethodsTwo hundred and fifty-four Brazilian TB patients using isoniazid (INH), rifampicin (RMP), and pirazinamide (PZA) were tested in a prospective cohort study. NAT2 genotyping was performed by direct PCR sequencing. The association between gastrointestinal ADRs/hepatotoxicity and the NAT2 profile genotype was evaluated by univariate analysis and multiple logistic regression.ResultsOf the 254 patients analyzed, 69 (27.2%) were slow acetylators and 185 (72.8%) were fast acetylators. Sixty-five (25.6%) patients were human immunodeficiency virus (HIV)-positive. Thirty-three (13%) and 14 (5.5%) patients developed gastrointestinal ADR and hepatotoxicity, respectively. Of the 14 hepatotoxicity patients, nine (64.3%) were slow acetylators and five (35.7%) were fast acetylators. Sex, age, presence of hepatitis C virus, alcohol abuse, and baseline aminotransferases were not found to be risk factors for hepatotoxicity. However, logistic regression analysis revealed that slow acetylator status and the presence of HIV (p < 0.05) were independent risk factors for hepatotoxicity.ConclusionsOur findings show that HIV-positive patients that have the slow acetylation profile are significantly associated with a higher risk of developing hepatotoxicity due to anti-TB drugs.


BMC Microbiology | 2009

Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.

Elis Regina Dalla Costa; Marta Osório Ribeiro; Márcia Susana Nunes Silva; Liane Silveira Arnold; Diana Rostirolla; Patrícia Izquierdo Cafrune; Roger Espinoza; Moises Palaci; Maria Alice da Silva Telles; Viviana Ritacco; Philip Noel Suffys; Maria Luiza Lopes; Creuza Campelo; Silvana Spindola de Miranda; Kristin Kremer; Pedro Eduardo Almeida da Silva; Leila de Souza Fonseca; John L. Ho; Afranio Lineu Kritski; Maria Lucia Rosa Rossetti

BackgroundMutations associated with resistance to rifampin or streptomycin have been reported for W/Beijing and Latin American Mediterranean (LAM) strain families of Mycobacterium tuberculosis. A few studies with limited sample sizes have separately evaluated mutations in katG, ahpC and inhA genes that are associated with isoniazid (INH) resistance. Increasing prevalence of INH resistance, especially in high tuberculosis (TB) prevalent countries is worsening the burden of TB control programs, since similar transmission rates are noted for INH susceptible and resistant M. tuberculosis strains.ResultsWe, therefore, conducted a comprehensive evaluation of INH resistant M. tuberculosis strains (n = 224) from three South American countries with high burden of drug resistant TB to characterize mutations in katG, ahpC and inhA gene loci and correlate with minimal inhibitory concentrations (MIC) levels and spoligotype strain family. Mutations in katG were observed in 181 (80.8%) of the isolates of which 178 (98.3%) was contributed by the katG S315T mutation. Additional mutations seen included oxyR-ahpC; inhA regulatory region and inhA structural gene. The S315T katG mutation was significantly more likely to be associated with MIC for INH ≥2 μg/mL. The S315T katG mutation was also more frequent in Haarlem family strains than LAM (n = 81) and T strain families.ConclusionOur data suggests that genetic screening for the S315T katG mutation may provide rapid information for anti-TB regimen selection, epidemiological monitoring of INH resistance and, possibly, to track transmission of INH resistant strains.


Memorias Do Instituto Oswaldo Cruz | 2008

Mycobacterium tuberculosis strains of the Beijing genotype are rarely observed in tuberculosis patients in South America

Viviana Ritacco; Patrícia Izquierdo Cafrune; Lucilaine Ferrazoli; Philip Noel Suffys; Norma Candia; Lucy Vásquez; Teresa Realpe; Jorge Fernández; Karla Valéria Batista Lima; Jeannete Zurita; Jaime Robledo; Maria Lucia Rosa Rossetti; Afranio Lineu Kritski; Maria Alice da Silva Telles; Juan Carlos Palomino; Herre Heersma; Dick van Soolingen; Kristin Kremer; Lucía Barrera

The frequency of the Beijing genotype of Mycobacterium tuberculosis as a cause of tuberculosis (TB) in South America was determined by analyzing genotypes of strains isolated from patients that had been diagnosed with the disease between 1997 and 2003 in seven countries of the subcontinent. In total, 19 of the 1,202 (1.6%) TB cases carried Beijing isolates, including 11 of the 185 patients from Peru (5.9%), five of the 512 patients from Argentina (1.0%), two of the 252 Brazilian cases (0.8%), one of the 166 patients from Paraguay (0.6%) and none of the samples obtained from Chile (35), Colombia (36) and Ecuador (16). Except for two patients that were East Asian immigrants, all cases with Beijing strains were native South Americans. No association was found between carrying a strain with the Beijing genotype and having drug or multi-drug resistant disease. Our data show that presently transmission of M. tuberculosis strains of the Beijing genotype is not frequent in Latin America. In addition, the lack of association of drug resistant TB and infection with M. tuberculosis of the Beijing genotype observed presently demands efforts to define better the contribution of the virulence and lack of response to treatment to the growing spread of Beijing strains observed in other parts of the world.


Infection, Genetics and Evolution | 2012

Spoligotypes of Mycobacterium tuberculosis complex isolates from patients residents of 11 states of Brazil

Harrison Magdinier Gomes; Atina Ribeiro Elias; Maranibia Aparecida Cardoso Oelemann; Marcia Aparecida da Silva Pereira; Fátima Fandinho Onofre Montes; Ana Grazia Marsico; Afrânio Lineu Kritski; Luciano dos Anjos Filho; Paulo Cesar de Souza Caldas; Lia Gonçalves Possuelo; Patrícia Izquierdo Cafrune; Maria Lucia Rosa Rossetti; Norma Lucena; Maria Helena Féres Saad; Hebe Rodrigues Cavalcanti; Clarisse Queico Fujimura Leite; Rossana Coimbra Brito; Maria Luiza Lopes; Karla Valéria Batista Lima; Maisa Souza; Rita de Cássia Trindade; Thierry Zozio; Christophe Sola; Nalin Rastogi; Philip Noel Suffys

One of the high tuberculosis (TB) incidence countries in the world, Brazil is characterized by considerable differences in TB incidence on regional and state level. In the present study, we describe Brazilian spoligotypes of 1991 Mycobacterium tuberculosis complex (MTC) clinical isolates from patients residents of 11 states from different regions of the country, diagnosed between 1996 and 2005. By performing spoligotyping on a large number of M. tuberculosis clinical isolates, one of the main objectives of this study was to determine the major genotype families causing TB in Brazil and to verify the region-associated genotype distribution. We observed a total of 577 distinct spoligopatterns, 12.6% of these corresponded to orphan patterns while 87.4% belonged to 326 shared-types (SITs). Among the latter, 86 SITs (isolated from 178 patients) had been observed for the first time in this study, the most frequent being SIT2517 which belonged to the T3-ETH lineage and was exclusively found among patients residents of Belém, the capital of the state of Pará (n=8 isolates). Irrespective of shared-type labeling, a total of 19.5% strains were unique (unclustered) in our study as opposed to 80.5% clustered isolates (189 clusters, size range from 2 to 205 isolates). The three largest clusters were SIT42 of the Latin-America & Mediterranean (LAM) 9 clade (10.3%), SIT53 of the T clade (7.6%), and SIT50 of the Haarlem clade (5.4%). The predominant MTC lineages in Brazil in decreasing order belonged to the LAM (46%); the ill-defined T (18.6%); the Haarlem (12.2%), the X (4.7%), the S (1.9%), and the East African Indian (EAI) (0.85%) families. The rest of clades grouped together as Mycobacterium africanum, Mycobacterium bovis, Beijing, Central Asian (CAS), and the Manu types, represented less than 1% of the strains. Finally, about 15% of the isolates showed spoligotype signatures that were not yet classified among well-defined lineages. In conclusion, we provide hereby a first insight into the population structure of MTC isolates in Brazil, showing the predominance of both LAM and T family and the existence of region-associated genotypes.


Antimicrobial Agents and Chemotherapy | 2005

Characterization of pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis in Brazil

Vívian de F.S. Rodrigues; Maria Alice da Silva Telles; Marta Osório Ribeiro; Patrícia Izquierdo Cafrune; Maria Lucia Rosa Rossetti; Arnaldo Zaha

ABSTRACT In this study the nucleotide sequence of the pncA gene from 59 Mycobacterium tuberculosis clinical isolates was analyzed. Mutations in the pncA gene were identified in 29 of 40 pyrazinamide-resistant isolates, and no pyrazinamidase activity was detected in 39 of them. Twelve mutations found in this work have not been described previously.


Memorias Do Instituto Oswaldo Cruz | 2012

Tuberculosis in a southern Brazilian prison

Daniele Kuhleis; Andrezza Wolowski Ribeiro; Elis Regina Dalla Costa; Patrícia Izquierdo Cafrune; Karen Barros Schmid; Lucas Laux da Costa; Marta Osório Ribeiro; Arnaldo Zaha; Maria Lucia Rosa Rossetti

The occurrence of tuberculosis (TB) in prisons has been described as an alarming public health problem in many countries, especially in developing nations. The objective of this study was to conduct a survey among prisoners with TB respiratory symptoms in order to estimate the incidence of the disease, to analyze the drug susceptibility profile and genotype the isolates of Mycobacterium tuberculosis in the city of Charqueadas, southern of Brazil. The TB incidence was 55/1,900 inhabitants in the prison; this corresponds to an incidence of 3,789/100,000 inhabitants, with a prevalence of 72/1,900 (4,960/100,000 inhabitants). Drug susceptibility test was performed and, among the analyzed isolates, 85% were susceptible to all drugs tested and 15% were resistant to at least one drug, of which 89% were resistant only to isoniazid (INH) or in combination with another drug. The genotype classification of spoligotyping analysis showed that 40% of the isolates belong to LAM family, 22% to T family, 17.5% to Haarlem family, 12.5% to U family and 3% to X family. The shared international spoligotypes most frequently found were 729 (27%), 50 (9.5%), 42 (8%), 53 (8%) and 863 (8%). In conclusion, it was observed that TB in this specific population had been caused, mostly, by strains that have been transmitted in the last few years, as demonstrated by the large level of genotype clustering. In addition, it was found specific large clusters, which were not often found in the general population from the same period and in the same region.


Memorias Do Instituto Oswaldo Cruz | 2011

Colorimetric microwell plate reverse-hybridization assay for Mycobacterium tuberculosis detection

Candice Tosi Michelon; Franciele Rosso; Karen Barros Schmid; Rosa Dea Sperhacke; Martha Maria Oliveira; Afrânio Lineu Kritski; Leonides Rezende Jr; Elis Regina Dalla Costa; Andrezza Woloski Ribeiro; Patrícia Izquierdo Cafrune; Márcia Susana Nunes Silva; Daniele Kuhleis; Arnaldo Zaha; Maria Lucia Rosa Rossetti

Direct smear examination using Ziehl-Neelsen staining for pulmonary tuberculosis (PTB) diagnosis is inexpensive and easy to use, but has the major limitation of low sensitivity. Rapid molecular methods are becoming more widely available in centralized laboratories, but they depend on timely reporting of results and strict quality assurance obtainable only from costly commercial kits available in high burden nations. This study describes a pre-commercial colorimetric method, Detect-TB, for detecting Mycobacterium tuberculosis DNA in which an oligonucleotide probe is fixed onto wells of microwell plates and hybridized with biotinylated polymerase chain reaction amplification products derived from clinical samples. The probe is capable of hybridising with the IS6110 insertion element and was used to specifically recognise the M. tuberculosis complex. When combined with an improved silica-based DNA extraction method, the sensitivity of the test was 50 colony-forming units of the M. tuberculosis reference strain H37Rv. The results that were in agreement with reference detection methods were observed in 95.2% (453/476) of samples included in the analysis. Sensitivity and specificity for 301 induced sputum samples and 175 spontaneous sputum samples were 85% and 98%, and 94% and 100%, respectively. This colorimetric method showed similar specificity to that described for commercially available kits and may provide an important contribution for PTB diagnosis.


Diagnostic Microbiology and Infectious Disease | 2008

Phenotypic and genotypic characterization of drug-resistant Mycobacterium tuberculosis strains.

Wanessa Trindade Clemente; Stella Sala Soares Lima; Moises Palaci; Márcia Susana Nunes Silva; Vívian de F.S. Rodrigues; Elis Regina Dalla Costa; Lia Gonçalves Possuelo; Patrícia Izquierdo Cafrune; Fabíola Karla Ribeiro; Harisson M. Gomes; José Carlos Serufo

Of 142 pulmonary tuberculosis patients, 76 were considered high risk for the development of resistance, and 24 were confirmed as resistant strain carriers. Resistant isoniazid strains presented a high frequency of katG and ahpC mutations (90%) correlated with an MIC >4 microg/mL (94%). inhA mutations were not seen. rpoB mutations were identified in 78.6% of rifampicin-resistant strains, usually in codon 531 (72.7%), and 75% had an MIC >16 microg/mL. katG and rpoB mutations recognized 88.2% of multidrug-resistant strains and proved more efficient than the katG and rpoB mutations alone. Seventy percent of resistant pyrazinamide strains had pncA mutations between genes 136 and 188, 62.5% of them with an MIC >900 microg/mL. Pyrazinamidase inactivity was not an efficient resistance marker because 60% of pncA-mutated strains maintained enzymatic activity despite displaying good correlation with high resistance levels. Resistant ethambutol strains had embB mutations in codon 306, with MIC >16 microg/mL.


BMC Public Health | 2007

PCR colorimetric dot-blot assay and clinical pretest probability for diagnosis of Pulmonary Tuberculosis in smear-negative patients.

Luciene Cardoso Scherer; Rosa Dea Sperhacke; Carla Jarczewski; Patrícia Izquierdo Cafrune; Simone Minghelli; Marta Osório Ribeiro; Fernanda Cq Mello; Antonio Ruffino-Netto; Maria Lr Rossetti; Afrânio Lineu Kritski

BackgroundSmear-negative pulmonary tuberculosis (SNPTB) accounts for 30% of Pulmonary Tuberculosis (PTB) cases reported annually in developing nations. Polymerase chain reaction (PCR) may provide an alternative for the rapid detection of Mycobacterium tuberculosis (MTB); however little data are available regarding the clinical utility of PCR in SNPTB, in a setting with a high burden of TB/HIV co-infection.MethodsTo evaluate the performance of the PCR dot-blot in parallel with pretest probability (Clinical Suspicion) in patients suspected of having SNPTB, a prospective study of 213 individuals with clinical and radiological suspicion of SNPTB was carried out from May 2003 to May 2004, in a TB/HIV reference hospital. Respiratory specialists estimated the pretest probability of active disease into high, intermediate, low categories. Expectorated sputum was examined by direct microscopy (Ziehl-Neelsen staining), culture (Lowenstein Jensen) and PCR dot-blot. Gold standard was based on culture positivity combined with the clinical definition of PTB.ResultsIn smear-negative and HIV subjects, active PTB was diagnosed in 28.4% (43/151) and 42.2% (19/45), respectively. In the high, intermediate and low pretest probability categories active PTB was diagnosed in 67.4% (31/46), 24% (6/25), 7.5% (6/80), respectively. PCR had sensitivity of 65% (CI 95%: 50%–78%) and specificity of 83% (CI 95%: 75%–89%). There was no difference in the sensitivity of PCR in relation to HIV status. PCR sensitivity and specificity among non-previously TB treated and those treated in the past were, respectively: 69%, 43%, 85% and 80%. The high pretest probability, when used as a diagnostic test, had sensitivity of 72% (CI 95%:57%–84%) and specificity of 86% (CI 95%:78%–92%). Using the PCR dot-blot in parallel with high pretest probability as a diagnostic test, sensitivity, specificity, positive and negative predictive values were: 90%, 71%, 75%, and 88%, respectively. Among non-previously TB treated and HIV subjects, this approach had sensitivity, specificity, positive and negative predictive values of 91%, 79%, 81%, 90%, and 90%, 65%, 72%, 88%, respectively.ConclusionPCR dot-blot associated with a high clinical suspicion may provide an important contribution to the diagnosis of SNPTB mainly in patients that have not been previously treated attended at a TB/HIV reference hospital.

Collaboration


Dive into the Patrícia Izquierdo Cafrune's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marta Osório Ribeiro

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Arnaldo Zaha

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Lia Gonçalves Possuelo

Universidade de Santa Cruz do Sul

View shared research outputs
Top Co-Authors

Avatar

Andrezza Wolowski Ribeiro

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Daniele Kuhleis

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Elis Regina Dalla Costa

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Karen Barros Schmid

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Rosa Dea Sperhacke

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Afrânio Lineu Kritski

Federal University of Rio de Janeiro

View shared research outputs
Researchain Logo
Decentralizing Knowledge